News
Offering a modest gift card significantly increased enrollment of low-income individuals in a patient registry designed to ...
Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.
In this Healio Video Perspective, Dante J. Pieramici, MD, discusses a trial investigating contrast sensitivity as a visual ...
Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...
NEW YORK – Krystal Biotech has discontinued a Phase I/II clinical trial evaluating an injected version of its gene therapy KB707 in locally advanced or metastatic solid tumors, including melanoma.
Offering a modest gift card significantly increased enrollment of low-income individuals in a patient registry designed to ...
ALEX TORDOFF is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut.
Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...
NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...
HBAR tests key support at $0.23 after a 3% pullback Friday, with resistance forming near $0.24. Bullish catalysts emerge as ...
Clinical trials test the safety and effectiveness of new cancer drugs and treatments. Search for Huntsman Cancer Institute clinical trials by cancer type, drug, or doctor.
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results